API HOLDINGS ( PharmEasy)

LTP : ₹ 9.10

Industry : E-commerce company

LTP : ₹ 9.10

watchlist

Overview

PharmEasy is a consumer healthcare Company that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceutical, other consumer healthcare products, comprehensive diagnostic test services, and teleconsultants.

Company Info

INE0DJ201029
Pharmeasy
https://pharmeasy.in/
18 August 2022
301, B- Wing, Raheja Plaza 1, Opposite R-city Mall, L.B.S Marg, Ghatkopar West, Mumbai 400086

Market Depth

Buy Price Orders Qty
No Active Buyer
Sell Price Orders Qty
No Active Seller

Ratios
Market Capitalization N/A Price High-Low 13.75 - 8.25
Stock P/E N/A 3 Yr CAGR Revenue
EPS N/A ROCE N/A
Particular 2019 2020 2021 2022 2023 2024
No Record Active
Particular 2019 2020 2021 2022 2023 2024
No Record Active
Particular 2021 icon
Cash flow from Operating activities -813.68
Net Profit/Loss Before Extraordinary Income and Tax -813.68
Extraordinary Item 0.00
Add: Non cash & Non Operating Expenses 0.00
Less: Non cash & Non Operating Incomes 0.00
Adjustment for changes in working capital (NET) 0.00
Tax Paid 0.00
Cash Flow From Investing activities 0.00
Capital Expenditures 0.00
Interest/Dividend Income 0.00
Others 0.00
Cash Flow From Financing activities 0.00
Interest Paid 0.00
Dividend Paid 0.00
Others 0.00
Net Increase/Decrease in Cash and Cash Equivalents 0.00
Opening Balance of cash & Cash Equivalent 0.00
Closing Cash & Cash Equivalents 0.00
Free Cash Flow 0.00
Name Number of Shares % Holding
Public Institution Holding 70.38 0%
Public Non- Institution Holding 10.30 0%
Other 19.32 0%
Date Investors No. of Investors Amount Series
01 November 2021 VestinWolf Capital Management 1 - 0.00 - Private Equity Round
20 October 2021 Trifecta Capital Advisors 1 - 0.00 - Debt Financing
18 October 2021 IIFL Finance 1 - 146.00 - Secondary Market
18 October 2021 8 - 204.00 - Venture Round
07 July 2021 Arokiaswamy Velumani 8 - 500.00 - Series F
17 June 2021 B Capital Group 1 - 20.00 - Secondary Market
07 April 2021 Prosus Ventures, TPG Growth 18 - 390.00 - Series E
07 April 2021 Prosus Ventures, TPG Growth 18 - 390.00 - Series E
27 November 2019 Temasek Holdings 8 - 220.00 - Series D
26 September 2018 Eight Roads Ventures India 7 - 50.00 - Series C
11 September 2018 InnoVen Capital 1 - 400.00 - Debt Financing

Name Industry Announced Date Amount
Aknamed - 14 September 2021 144.00
Thyrocare Technologies - 26 June 2021 45.50
Medlife - 18 August 2020 235.00

Name Announced Date Amount
No Record Active

Name Organization
Akna Medical Private Limited https://www.aknamed.com/
Medlife Wellness Retail Private Limited www.medlife.com
Thyrocare Technologies Limited https://www.thyrocare.com/
Corporate Actions
Action Date
No Record Active
Company Status
STUDDS ACCESSORIES LIMITED Listed
News & Updates
30 June 2023

Indian travel market may see 40% gr...

30 June 2023

Ixigo Invests In E-Bus Startup Fres...

30 June 2023

Ixigo-backed Fresh Bus commences op...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. See our Privacy and Cookies Policy